Squarepoint Ops LLC Molecular Templates, Inc. Transaction History

Squarepoint Ops LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.27 - $4.13 $51,499 - $93,697	-22,687 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.37 - $6.87 $76,455 - $155,859	22,687 New	22,687 $89,000
Q2 2021 Aug 16, 2021	SELL	$7.82 - $12.44 $222,666 - $354,216	-28,474 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.33 - $14.05 $552,447 - $831,928	-59,212 Reduced 67.53%	28,474 $359,000
Q4 2020 Feb 16, 2021	BUY	$8.48 - $12.23 $359,721 - $518,796	42,420 Added 93.71%	87,686 $823,000
Q3 2020 Nov 16, 2020	SELL	$9.99 - $14.41 $89,510 - $129,113	-8,960 Reduced 16.52%	45,266 $494,000
Q2 2020 Aug 14, 2020	BUY	$12.28 - $17.63 $484,077 - $694,974	39,420 Added 266.24%	54,226 $748,000
Q1 2020 May 15, 2020	BUY	$11.31 - $18.26 $167,455 - $270,357	14,806 New	14,806 $197,000
Q4 2019 Feb 14, 2020	SELL	$6.44 - $14.21 $68,521 - $151,194	-10,640 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.6 - $8.46 $48,943 - $90,014	10,640 New	10,640 $70,000
Q2 2018 Aug 14, 2018	SELL	$5.19 - $9.71 $57,609 - $107,781	-11,100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.0 - $12.96 $88,800 - $143,856	11,100 New	11,100 $89,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $10.1M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.